What are the uses of epidocin (valethamate bromide), drotin (drotaverine) and oxytocin in the labour theatre, and at what stages of labour are each medication administered?

Uses of Epidocin, Drotin, and Oxytocin in Labour Theatre

Oxytocin is the primary evidence-based medication for labour augmentation and should be used during the active phase of labour (≥5 cm cervical dilatation) when contractions are inadequate, while epidocin (valethamate bromide) and drotin (drotaverine) lack robust guideline support and should be considered adjunctive agents used earlier in labour (around 4 cm dilatation) to facilitate cervical dilatation, not as substitutes for oxytocin.

Oxytocin - The Gold Standard

Oxytocin is the only medication with strong guideline support for labour management 1. According to FDA labeling, oxytocin must be administered only by intravenous route with adequate medical supervision in a hospital 2.

Timing and Indications:

• Active phase labour (≥5 cm dilatation): Use when contractions are poor quality or infrequent 1
• Protracted active phase: When cervical dilatation is <1 cm per 4 hours in early active phase, or <1 cm per 2 hours above 7 cm 3
• Arrest of labour: After 2-4 hours of no cervical change (recent evidence suggests 2 hours is safer) 1
• Second stage prolongation: Beyond 2 hours without progress 3

Dosing Protocol:

The FDA-approved regimen starts at 1-2 mIU/min, with gradual increases of 1-2 mIU/min at intervals of at least 30 minutes, not exceeding 20 mIU/min maximum 2, 3. Careful titration is essential to avoid uterine hyperstimulation 1.

Critical Safety Points:

• Rule out cephalopelvic disproportion (CPD) before use - 40-50% of arrest cases have CPD 1
• Avoid if evidence of CPD emerges (marked molding, deflexion, asynclitism without descent) 1
• Stop immediately if uterine hyperactivity or fetal distress occurs 2
• Requires continuous fetal heart rate and contraction monitoring 2

Drotin (Drotaverine) - Cervical Dilatation Facilitator

Drotaverine is an antispasmodic that may accelerate cervical dilatation but lacks guideline-level evidence.

Timing and Use:

• Given at 4 cm cervical dilatation 4, 5
• Administered intramuscularly, repeated hourly for maximum 3 doses 4
• Works by facilitating cervical dilatation, not by enhancing contractions

Evidence Base:

Research shows drotaverine reduces first stage duration by approximately 15% with mean cervical dilatation rate of 3 cm/hour versus 1.9 cm/hour in controls 4. Maximum benefit (28% reduction) occurs when given at 4 cm dilatation 5.

Advantages over Valethamate:

• Fewer side effects (mainly headache) 4
• No feto-maternal tachycardia or anticholinergic effects 4

Important Caveat:

One study noted increased atonic postpartum hemorrhage with drotaverine 5, requiring vigilance in third stage management.

Epidocin (Valethamate Bromide) - Alternative Cervical Dilator

Valethamate is an anticholinergic agent that may shorten first stage labour but has no guideline support and more side effects than drotaverine.

Timing and Use:

• Given at 4 cm cervical dilatation 4
• Intramuscular administration, repeated hourly for maximum 3 doses 4
• Mean cervical dilatation rate: 2.4 cm/hour versus 1.9 cm/hour in controls 4

Side Effects:

• Feto-maternal tachycardia 4
• Facial flushing 4
• Dry mouth 4
• Anticholinergic effects 6

Evidence Quality:

Studies are older (1999-2010) and lack the rigor of oxytocin trials 4, 6.

Clinical Algorithm for Labour Theatre

1. Latent Phase (<5 cm dilatation):

• Do NOT use oxytocin routinely 3
• Consider drotaverine or valethamate at 4 cm if cervical dystocia suspected 4
• Avoid routine amniotomy 3

2. Active Phase (≥5 cm dilatation) with Adequate Contractions:

• Expectant management
• No routine oxytocin needed

3. Active Phase with Inadequate Contractions:

• First-line: Amniotomy 3
• If no improvement within 1 hour: Start oxytocin 3
• Critical: Rule out CPD before oxytocin 1

4. Arrest of Active Phase (no change for 2-4 hours):

• Thorough cephalopelvimetry to exclude CPD 1
• If no CPD: Oxytocin infusion 1
• Monitor for 2 hours (safer than 4 hours) 1
• If no response: Proceed to cesarean delivery 1

5. Second Stage Prolongation (>2 hours):

• Oxytocin for dynamic dystocia 3

Key Pitfalls to Avoid

• Never use oxytocin in presence of CPD - this is associated with 25-30% of protracted labour and 40-50% of arrest cases 1
• Do not use high-dose oxytocin protocols without proper monitoring - requires infusion pump and continuous fetal/contraction monitoring 2
• Avoid using drotaverine/valethamate as substitutes for oxytocin - they facilitate cervical dilatation but don't enhance contractions like oxytocin 4
• Do not continue oxytocin if no progress after 2 hours - proceed to cesarean delivery 1
• Watch for uterine hyperstimulation - oxytocin infusion must be stopped immediately if this occurs 2

Evidence Hierarchy

The 2023 AJOG guidelines provide the strongest evidence for oxytocin use 1, supported by FDA labeling 2 and recent comprehensive reviews 7, 8. Drotaverine and valethamate have only research-level evidence from smaller studies 4, 6, 5, with drotaverine showing superiority over valethamate in comparative trials 4.